newsfilter
← Latest News
Business Wire·

Veracyte Names Kevin Haas as Chief Development and Technology Officer

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, announced today that Kevin Haas, Ph.D., has been appointed Chief Development and Technology Officer, a newly created leadership role designed to